TNBC refers to the breast cancer subtype lacking expression of estrogen receptor (ER), progesterone receptor (PR), and lacking over expression human epidermal growth factor receptor 2(HER2), which account for approximately 15% of breast cancers (1, 2). This evidence concerns the gene ESR1 and breast cancer.